anti-Protein O-Linked Mannose Beta1,2-N-Acetylglucosaminyltransferase (POMGNT1) Anticorps

The protein encoded by POMGNT1 is a type II transmembrane protein that resides in the golgi. De plus, nous expédions Protein O-Linked Mannose Beta1,2-N-Acetylglucosaminyltransferase Kits (8) et Protein O-Linked Mannose Beta1,2-N-Acetylglucosaminyltransferase Protéines (7) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
POMGNT1 68273 Q91X88
POMGNT1 55624 Q8WZA1
POMGNT1 362567 Q5XIN7
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-Protein O-Linked Mannose Beta1,2-N-Acetylglucosaminyltransferase Anticorps sur anticorps-enligne.fr

Showing 10 out of 23 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Boeuf (Vache) Lapin Inconjugué WB WB Suggested Anti-Pomgnt1 Antibody   Titration: 1.0 ug/ml   Positive Control: Mouse Brain 100 μL 2 to 3 Days
$289.00
Détails
Humain Lapin Inconjugué ICC, IF, IHC (p), WB IHC-P Image POMGNT1 antibody detects POMGNT1 protein at cytoplasm in mouse liver by immunohistochemical analysis. Sample: Paraffin-embedded mouse liver. POMGNT1 antibody , diluted at 1:500. IHC-P Image Immunohistochemical analysis of paraffin-embedded Cal27 xenograft , using POMGNT1, antibody at 1:500 dilution. 100 μL 3 to 4 Days
$466.18
Détails
Boeuf (Vache) Lapin Inconjugué WB 100 μL 11 to 14 Days
$551.83
Détails
Humain Souris Inconjugué ELISA, IHC, IHC (p), WB 100 μg 11 to 14 Days
$551.83
Détails
Humain Lapin Inconjugué IHC, WB Western blot analysis of extracts of various cells, using POMGNT1 antibody. Immunohistochemistry of paraffin-embedded human prostate using POMGNT1 antibody at dilution of 1:100 (x40 lens). 100 μL 11 to 13 Days
$366.77
Détails
Humain Lapin Inconjugué ICC, IHC, IHC (p), WB   100 μL 11 to 14 Days
$537.17
Détails
Humain Souris Inconjugué IHC (p), ELISA, WB Immunoperoxidase of monoclonal antibody to POMGNT1 on formalin-fixed paraffin-embedded human liver. [antibody concentration 3 ug/ml] Western Blot detection against Immunogen (36.52 KDa) . 100 μg 11 to 12 Days
$440.00
Détails
Humain Lapin Inconjugué IF/ICC, IHC (fp), WB   100 μL 6 to 8 Days
$431.20
Détails
Humain Lapin Inconjugué IF, IHC, WB   100 μL 2 to 3 Days
$429.00
Détails
Humain Lapin Biotin ELISA   100 μg 11 to 16 Days
$469.05
Détails

Plus d’anticorps contre Protein O-Linked Mannose Beta1,2-N-Acetylglucosaminyltransferase partenaires d’interaction

Mouse (Murine) Protein O-Linked Mannose Beta1,2-N-Acetylglucosaminyltransferase (POMGNT1) interaction partners

  1. Findings suggest that PomGnT1 promotes GBM progression via activation of beta-catenin and may serve as a prognostic factor for glioma patient survival as well as a novel molecular target for anticancer therapy in malignant glioma.

  2. POMGnT1 gene knockout cause basement membrane disruptions in a mouse model of dystroglycanopathy.

  3. Results describe the effect of altered glycosylation of alpha-dystroglycan caused by inactivation of POMGnT1 in the retina.

  4. classical beta1,2-elongation and beta1,6-GlcNAc branching of O-mannose glycan structures are dependent upon the POMGnT1 enzyme and O-mannosylation is not limited solely to alpha-DG in the brain

  5. POMGnT1 knockout mice were viable but with reduced fertility and variable lifespan

  6. The present study provides the first genetic animal model to further dissect the roles of POMGnT1 in MEB disease.

  7. From these findings, we propose that fukutin forms a complex with POMGnT1 and may modulate its enzymatic activity.

  8. POMGnT1(-/-) muscle showed minimal pathological changes with very low-serum creatine kinase levels, and had normally formed muscle basal lamina, but showed reduced muscle mass, reduced numbers of muscle fibers, and impaired muscle regeneration.

Human Protein O-Linked Mannose Beta1,2-N-Acetylglucosaminyltransferase (POMGNT1) interaction partners

  1. Genetic testing revealed two known heterozygous mutations in the POMGnT1 gene confirming muscular dystrophy-dystroglycanopathy type A (MDDGA3), one of a group of diseases collectively known as congenital muscular dystrophies, is an alpha-dystroglycanopathy with characteristic brain and ocular abnormalities.

  2. Next-generation sequencing data analysis revealed that all three muscle-eye-brain disease patients had the same novel copy number variations (CNV) g.6668-8257del, which was homozygous in patient 1 and heterozygous in patients 2 and 3.

  3. These findings demonstrate that PomGnT1 might be a new focus of glioblastoma (GBM)research for treatment of recurrent Temozolomide -resistant GBM

  4. The authors have identified a novel mutation in POMGNT1 that causes nonsyndromic autosomal recessive retinitis pigmentosa, adding to the genetic heterogeneity of this retinal disease.

  5. Study identified recessive POMGNT1 mutations in three unrelated non-syndromic retinitis pigmentosa families showing significant impaired POMGNT1 enzymatic activity.

  6. When association tests were applied to data from the Diabetes Heart Study, it found exome variants of POMGNT1 and JAK1 genes were associated with type 2 diabetes.

  7. POMGNT1 Is Glycosylated by Mucin-Type O-Glycans

  8. study presents clinical, neuroradiological, and POMGNT1 findings in 12 muscle-eye-brain disease patients of Turkish origin from 10 families; suggests a genotype-phenotype correlation

  9. Data indicate that Golgi phosphoprotein 3 (GOLPH3) binds to and controls the Golgi localization of protein O-linked mannose beta-1,2-N-acetlyglucosaminyltransferase 1 (POMGnT1).

  10. Identification of novel POMGnT1 mutations in Chinese patients with muscle-eye-brain disease.

  11. POMGnT1 point mutations and protein expression are associated with variably severe muscle-eye-brain disease showing that severity of the phenotype does not correlate with protein expression.

  12. Promoter alteration causes transcriptional repression of the POMGNT1 gene in limb-girdle muscular dystrophy type 2O.

  13. This study demonistreated that Intragenic rearrangements in POMGNT1 gene in muscle-eye-brain disease.

  14. these results show that the amino acid sequence affects POMGnT1 activity.

  15. This study gives a comprehensive biochemical evaluation of all clinically relevant POMGnT1 point mutations known to date, which have been linked to muscle-eye-brain disease or similar conditions.

  16. the function of the gene products is only known for POMT1, POMT2, and POMGnT1, all responsible for the O-mannosylglycan biosynthesis

  17. Merosin-deficient congenital muscular dystrophy with mental retardation and cerebellar cysts, unlinked to the MEB locus, in three Tunisian patients

  18. Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease. 13 mutations have been identified in patients with MEB. The mutant POMGnT1s were expressed and none had any activity.

  19. Results describe the identification of a novel O-linked mannose beta1,2-N-acetylglucosaminyltransferase (POMGnT1) gene missense mutation in muscle-eye-brain disease.

  20. DNA mutational analysis and phenotypes in patients with muscle-eye-brain disease

Protein O-Linked Mannose Beta1,2-N-Acetylglucosaminyltransferase (POMGNT1) profil antigène

Profil protéine

The protein encoded by this gene is a type II transmembrane protein that resides in the golgi. It participates in O-mannosyl glycosylation, and is specific for alpha linked terminal mannose. Mutations in this gene are associated with muscle-eye-brain (MEB) disease. Alternatively spliced transcript variants have been found for this gene.

Gene names and symbols associated with POMGNT1

  • protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) (POMGNT1) anticorps
  • protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) S homeolog (pomgnt1.S) anticorps
  • protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) (pomgnt1) anticorps
  • protein O-linked mannose beta 1,2-N-acetylglucosaminyltransferase (Pomgnt1) anticorps
  • protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) (Pomgnt1) anticorps
  • 0610016I07Rik anticorps
  • 4930467B06Rik anticorps
  • gnT-I.2 anticorps
  • GNTI.2 anticorps
  • GnT I.2 anticorps
  • im:7151461 anticorps
  • LGMD2O anticorps
  • MDDGA3 anticorps
  • MDDGB3 anticorps
  • MDDGC3 anticorps
  • MEB anticorps
  • MGAT1.2 anticorps
  • POMGNT1 anticorps
  • zgc:158130 anticorps

Protein level used designations for POMGNT1

protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase , O-linked mannose beta1,2-N-acetylglucosaminyltransferase , protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 , O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 , O-mannosyl N-acetylglucosaminyltransferase , UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2

GENE ID SPECIES
429097 Gallus gallus
456564 Pan troglodytes
482511 Canis lupus familiaris
495292 Xenopus laevis
571876 Danio rerio
707205 Macaca mulatta
100158594 Xenopus (Silurana) tropicalis
100174367 Pongo abelii
100590586 Nomascus leucogenys
68273 Mus musculus
506551 Bos taurus
55624 Homo sapiens
362567 Rattus norvegicus
Fournisseurs de qualité sélectionnés pour anti-Protein O-Linked Mannose Beta1,2-N-Acetylglucosaminyltransferase (POMGNT1) Anticorps
Avez-vous cherché autre chose?